Evolva Holding SA represents core values of innovation, sustainability, and collaboration. As a biotech company, Evolva is driven by a strong commitment to creating sustainable and environmentally friendly solutions for various industries. With a focus on biosynthesis and fermentation, the company aims to revolutionize the production of ingredients, compounds, and molecules. Evolva's corporate philosophy revolves around utilizing cutting-edge technology, fostering partnerships, and delivering value to customers and stakeholders. By continually pushing the boundaries of science and embracing a collaborative approach, Evolva strives to make a positive and lasting impact in sectors such as flavors and fragrances, health and wellness, and agriculture.

Evolva Holding SA is primarily present in various countries and regions worldwide. Some notable locations where the company operates include Switzerland, the United States, Germany, and France. Additionally, Evolva has a strong presence in other European countries, as well as in parts of Asia and South America. With its global reach, Evolva Holding SA continues to expand its market presence and collaborate with partners across different regions to deliver innovative solutions and drive growth in the field of sustainable ingredients.

Some significant milestones achieved by Evolva Holding SA include the successful commercialization of its innovative ingredients and products, such as its flagship ingredient nootkatone, a natural insect repellent. The company has also made advancements in its fermentation and biotechnology platforms, leading to the development of novel high-value ingredients for various industries. Furthermore, Evolva has established collaborations and partnerships with major players in the food, beverage, and personal care sectors. These milestones demonstrate Evolva Holding SA's commitment to research, development, and commercialization, positioning the company as a leader in sustainable and science-driven solutions.

Evolva Holding SA is a Swiss biotechnology company that specializes in the development and commercialization of innovative products for the healthcare, nutrition, and personal care sectors. Established in 2004, Evolva focuses on transforming nature's building blocks into high-value, sustainable ingredients using its proprietary technology platform. With a strong emphasis on research and development, the company has successfully created a portfolio of bio-based products, including specialty ingredients and natural compounds. Evolva's commitment to innovation and sustainability has garnered recognition across various industries, positioning the company as a trusted leader in biotechnology.

The main competitors of Evolva Holding SA in the market include companies like Ginkgo Bioworks, Amyris, and Intrexon. These companies operate in the field of biotechnology and specialize in the development and production of sustainable and natural ingredients. They, like Evolva Holding SA, contribute to the advancement of innovative and environmentally friendly solutions in various industries such as food, nutrition, and personal care. Through continuous research and development efforts, Evolva Holding SA strives to establish a strong competitive edge in the market and maintain a leading position among its industry counterparts.

Evolva Holding SA is primarily active in the industries of specialty ingredients and biomaterials.

The business model of Evolva Holding SA is centered around the production and commercialization of high-performance, sustainable ingredients for various industries. By leveraging its proprietary biotechnology platform, the company focuses on the development of innovative, nature-inspired products that can be used in sectors such as flavor and fragrance, nutrition, and personal care. Evolva's business model relies on partnerships and collaborations with industry leaders to bring these ingredients to market. Through continuous research and development, Evolva aims to deliver solutions that address global challenges while meeting the demand for sustainable, high-quality products. Evolva Holding SA is committed to revolutionizing ingredient production and contributing to a more sustainable future.

Rasio P/E Evolva Holding adalah -0,49.

Rasio KUV dari Evolva Holding adalah 0,22.

Skor Kualitas AlleAktien untuk Evolva Holding adalah 2/10.

Omset diharapkan Evolva Holding adalah 26,87 Juta. CHF.

Laba diharapkan Evolva Holding adalah -12,01 Juta. CHF.

The Evolva Holding SA is a company specialized in the development of specific active ingredients and additives for food and nutraceuticals. The company's business model is based on three sectors: food, health, and cosmetics. In the food sector, Evolva provides innovative solutions for food and beverage manufacturers, offering natural additives as substitutes for artificial flavorings and preservatives. In the health sector, Evolva develops known and novel active ingredients for nutraceuticals, including non-addictive analgesics such as GLPG2737. In the cosmetics sector, Evolva focuses on the production of natural ingredients, offering biotechnologically produced active substances with high efficacy and compatibility. The company collaborates closely with other companies to successfully market its products, licensing its technology platforms to generate new active ingredients and applications. Evolva's business model is characterized by a strong focus on research and development and cooperation with partners, aiming to increase the benefits of biotechnology for society and achieve long-term profitability.

Evolva Holding membayarkan dividen sebesar 0 CHF yang dibagi melalui pembayaran dalam setahun.

Dividen untuk Evolva Holding saat ini tidak dapat dihitung atau perusahaan tidak membagikan dividen.

ISIN dari Evolva Holding adalah CH0021218067.

WKN dari Evolva Holding adalah A0EAKH.

Ticker dari Evolva Holding adalah EVE.SW.

Dalam 12 bulan terakhir, Evolva Holding membayar dividen sebesar . Ini setara dengan yield dividen sekitar . Untuk 12 bulan mendatang, Evolva Holding diperkirakan akan membayar dividen sebesar 0 CHF.

Imbal hasil dividen dari Evolva Holding saat ini adalah .

Evolva Holding membayar dividen setiap kuartal. Dividen ini dibayarkan pada bulan .

Evolva Holding membayar dividen setiap tahun dalam 0 tahun terakhir.

Untuk 12 bulan ke depan, diperkirakan akan ada dividen sebesar 0 CHF. Ini setara dengan yield dividen sebesar 0 %.

Evolva Holding dikelompokkan dalam sektor 'Bahan Baku'.

Untuk menerima dividen terakhir dari Evolva Holding tanggal 19/11/2024 sejumlah 0 CHF, Anda harus memiliki saham tersebut di portofolio sebelum tanggal Ex-Tag pada 19/11/2024.

Pembayaran dividen terakhir dilakukan pada 19/11/2024.

Pada tahun 2023, Evolva Holding 0 CHF telah dibayarkan sebagai dividen.

Dividen dari Evolva Holding dibayarkan dalam CHF.